An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer
Katrine L Henriksen, Birgitte B Rasmussen, Anne E Lykkesfeldt, Susanne Møller, Bent Ejlertsen, Henning T Mouridsen
Dive into the research topics of 'An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer'. Together they form a unique fingerprint.